Evolving consumer expectations and a tightening regulatory environment drive the need for higher standards in the botanicals segment. This video on KSM-66 Ashwagandha outlines why an emphasis on vertical integration, testing, and accreditation is crucial to satisfying such demands.
Already have an account?
Sponsored by KSM-66: Ashwagandha
Responding to the need for more transparency in the nutraceuticals segment is today vital for manufacturers and brands. It’s about assuring quality, protecting the consumer, and safeguarding the sustainability of the sector.
Ixoreal Biomed, manufacturer of best-selling brand KSM-66 Ashwagandha, has long adhered to such principles, and has achieved exceptional standards across all such parameters via an unrivalled level of vertical integration throughout its entire production process – from seed to finished product.
Across the company’s vast acreage of dedicated organic farms in Rajasthan, and throughout its extensive complex of state-of-the-art, pharma-grade manufacturing facilities, it’s all about the testing. And attaining the level of safety and efficacy for which KSM-66 has become renowned worldwide has ultimately hinged on its command over all stages of the process – as the company’s CEO points out: “We are the only ashwagandha maker in the world that controls the entire supply chain.”
Check out the video to learn more about why vertical integration, alongside accreditation, have proved key for KSM-66 in nurturing trust amongst manufacturers and end-consumers alike across the globe.
